One bug's coat of many colors

Parasites can confuse their hosts' immune system by switching the proteins they display on their surface. But how? The intestinal parasite Giardi lamblia harnesses RNA interference to target which surface proteins to shut down, a study published tomorrow in Nature reports. "I actually think it's a superb paper," linkurl:Therdore Nash,;http://www3.niaid.nih.gov/labs/aboutlabs/lpd/gastrointestinalParasitesSection/ chief of gastrointestinal parasitology at the National Institute of Allergy and Inf

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Parasites can confuse their hosts' immune system by switching the proteins they display on their surface. But how? The intestinal parasite Giardi lamblia harnesses RNA interference to target which surface proteins to shut down, a study published tomorrow in Nature reports. "I actually think it's a superb paper," linkurl:Therdore Nash,;http://www3.niaid.nih.gov/labs/aboutlabs/lpd/gastrointestinalParasitesSection/ chief of gastrointestinal parasitology at the National Institute of Allergy and Infectious Disease, told The Scientist. "It's a very novel and unique mechanism of antigenic variation." Many important unicellular parasites, including malaria and other species of plasmodium, undergo antigenic variation, in which the parasite can switch which protein is expressed on its membrane surface to confuse and evade the host immune system. These parasites can have 50 to 300 genes encoding this family of surface proteins, but only express one on the surface of each cell at a time. Each parasite has a different mechanism by which they express one protein at a time. To evade the immune system, parasites like Giardia lamblia can spontaneously switch which protein they express. But as opposed to other parasites, Giardia lamblia switches proteins in the absence of a host and for no apparent reason. To find out the mechanism of this mysterious switching, the researchers, led by linkurl:Hugo Lujan;http://www.hhminews.org/research/scholars/lujan_bio.html at the Catholic University of Cordoba, Argentina, examined the transcription of surface protein genes in the parasites' nuclei. They discovered that all but one of the nearly 190 genes encoding for surface proteins (called variant-specific protein-- VSP -- genes) are shut off by RNA interference machinery, including RNA-dependent RNA polymerase, and the RNA cleaving proteins Dicer and Argonaute. By knocking out dicer and RNA polymerase, the cells would express hundreds of proteins on their surface. "We link for the first time the mechanism for RNAi with antigenic variation," Lujan told The Scientist, who was a research fellow in Nash's lab. "That was something that was very surprising." The next step is to determine what triggers this switch, Lujan said. Work on other parasites indicates that the presence of host immune cells initiates parasite surface protein switching. But since Giardia proteins switch even without the presence of a host, something else might be at work. Lujan is considering the role of epigenetics and how total surface protein expression may affect the switching rate. Nash pointed out that the surface proteins are not just there to evade host immune cells -- they also help the parasite adhere to host endothelial cells, perhaps suggesting other roles for the protein switching. "We don't' understand it fully," he said, "but it's a great model system for biology."
**__Related stories:__***linkurl:Stuck on Giardia;http://www.the-scientist.com/article/display/53895/
[December 2007]*linkurl:Malaria vax passes hurdle;http://www.the-scientist.com/blog/display/55268/
[8 December 2008]*linkurl:A new dynamic;http://www.the-scientist.com/toc/2007/05/01/
[May 2007]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies